As of 2025-09-18, the Intrinsic Value of Dyne Therapeutics Inc (DYN) is -14.51 USD. This DYN valuation is based on the model Peter Lynch Fair Value. With the current market price of 12.99 USD, the upside of Dyne Therapeutics Inc is -211.71%.
Based on its market price of 12.99 USD and our intrinsic valuation, Dyne Therapeutics Inc (DYN) is overvalued by 211.71%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -14.51 - -14.51 | -14.51 | -211.71% |
| P/E | (36.98) - (38.83) | (37.95) | -392.1% |
| DDM - Stable | (22.23) - (117.34) | (69.79) | -637.2% |
| DDM - Multi | (1.65) - (6.97) | (2.69) | -120.7% |
| Market Cap (mil) | 1,847.96 |
| Beta | 1.79 |
| Outstanding shares (mil) | 142.26 |
| Enterprise Value (mil) | 1,461.73 |
| Market risk premium | 4.60% |
| Cost of Equity | 9.68% |
| Cost of Debt | 5.00% |
| WACC | 6.68% |